Paper6237904
Mutational resistance to 4-quinolone antibacterial agents.
Smith JT. Eur J Clin Microbiol, 1984. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Mutational resistance to 4-quinolone antibacterial agents. Papers, record 6237904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6237904
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Escherichia coli | Major topic |
| Mutation | Major topic |
| Quinolines | Major topic |
| Ciprofloxacin | |
| Dose-Response Relationship, Drug | |
| Drug Resistance, Microbial | |
| Humans | |
| Nalidixic Acid | |
| Norfloxacin | |
| Ofloxacin | |
| Oxazines | |
| Species Specificity |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 337300 | Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/337300 | PubMed |
| 2 | 358918 | Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/358918 | PubMed |
| 3 | 4895844 | Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. | J Bacteriol | 1969 | https://conductscience.org/library/papers/4895844 | PubMed |
| 4 | 7019186 | The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts. | J Antimicrob Chemother | 1981 | https://conductscience.org/library/papers/7019186 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20696087 | Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. | Epidemiol Infect | 2011 | https://conductscience.org/library/papers/20696087 | PubMed |
| 20643497 | Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections. | J Hosp Infect | 2010 | https://conductscience.org/library/papers/20643497 | PubMed |
| 20229318 | Quantitative structure-activity relationship study of antitubercular fluoroquinolones. | Mol Divers | 2011 | https://conductscience.org/library/papers/20229318 | PubMed |
| 19218572 | Functional relationship between bacterial cell density and the efficacy of antibiotics. | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19218572 | PubMed |
| 7689456 | Quinolone mode of action--new aspects. | Drugs | 1993 | https://conductscience.org/library/papers/7689456 | PubMed |
| 3729343 | In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3729343 | PubMed |
| 3606077 | Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3606077 | PubMed |
| 3532944 | Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3532944 | PubMed |
| 3531024 | Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli. | Infection | 1986 | https://conductscience.org/library/papers/3531024 | PubMed |
| 3515312 | Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3515312 | PubMed |
| 3514470 | [Effect of pH value and magnesium on the antibacterial activity of quinolone preparations]. | Infection | 1986 | https://conductscience.org/library/papers/3514470 | PubMed |
| 3481314 | Chemotherapy of otitis media with ofloxacin. | Drugs | 1987 | https://conductscience.org/library/papers/3481314 | PubMed |
| 3435123 | Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435123 | PubMed |
| 3292209 | Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1988 | https://conductscience.org/library/papers/3292209 | PubMed |
| 3286517 | Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases. | Infection | 1988 | https://conductscience.org/library/papers/3286517 | PubMed |
| 3159571 | Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro. | Eur J Clin Microbiol | 1985 | https://conductscience.org/library/papers/3159571 | PubMed |
| 3085584 | In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3085584 | PubMed |
| 3065243 | Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review. | Infection | 1988 | https://conductscience.org/library/papers/3065243 | PubMed |
| 3019897 | [Inhibition of gyrase by 4-quinolones: effect on the structure of DNA]. | Infection | 1986 | https://conductscience.org/library/papers/3019897 | PubMed |
| 3015015 | Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6237904
GET https://conductscience.org/api/papers/v1/6237904/cited_by?page=2